畜牧与饲料科学 ›› 2011, Vol. 32 ›› Issue (4): 127-127.doi: 10.12160/j.issn.1672-5190.2011.04.069

• 药物科学 • 上一篇    

骨质疏松症治疗药物的研究进展

刘宇桐[1] 赵晓蕾[1] 王小瑜[1] 鲍丽[1] 撒楠[1] 魏长征[2] 金黎明[1]   

  1. [1]大连民族学院生命科学学院,辽宁大连116600 [2]上海第二军医大学附属长征医院骨科,上海200003
  • 出版日期:2011-04-20 发布日期:2011-04-20
  • 通讯作者: 刘宇桐
  • 作者简介:刘宇桐(1988-),男,主要研究方向为生物工程。 通讯作者:金黎明(1979-),女,副教授,博士,主要研究方向为生物活性物质。
  • 基金资助:
    大连民族学院“太阳鸟”项目

Research Progress in Therapeutic Drugs against Osteoporosis

LIU Yu-tong, ZHAO Xiao-lei, WANG Xiao-yu, BAO Li, SA Nan, WEI Chang-zheng, JIN Li-ming (1.College of Life Science, Dalian Nationalities University, Dalian 116600, China; 2. Department of Orthopedics, Changzheng Hospital of Second Military Medical University, Shanghai 200003, China)   

  • Online:2011-04-20 Published:2011-04-20

摘要: 骨质疏松症是以骨量减少、骨的微观结构退化为特征,致使骨的脆性增加并易于发生骨折的一种全身性骨骼疾病,是当前严重危害人类特别是绝经妇女和老人的疾病之一。近年来出现了许多预防和治疗骨质疏松症的药物,极大地推动了骨质疏松症理论基础的完善和临床治疗研究。就该领域的研究进展进行了简要综述。

Abstract: Osteoporosis is a general bone disease characterized by low bone mass and microarchitectural deterioration of bone tissue, which lead to bone fragility and a consequent susceptibility to fracture. It is one of serious diseases, which endangers health of humans, particularly postmenopausal women and old men. In recent years, a lot of drugs have been developed for prevention and treatment of osteoporosis and also largely promote development of clinical research and theoretics of osteoporosis. This article summarizes the overall development in therapeutic drugs against osteoporosis.

中图分类号: